The city of Evansville, Indiana, currently has 1 active clinical trials seeking participants for Diabetes research studies.
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Recruiting
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes and obesity that are already taking metformin. The study will last for about 89 weeks.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
01/22/2025
Locations: Qualmedica Research, LLC, Evansville, Indiana
Conditions: Type 2 Diabetes, Obesity